Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Tech medical study

Nighttime Light Linked to Schizophrenia Sleep Loss

Analysis based on 6 articles · First reported Sep 18, 2026 · Last updated Sep 21, 2026

Sentiment
5
Attention
1
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The study is a small, cross-sectional academic finding with no direct revenue or regulatory consequence, so its immediate effect on equity or credit markets is negligible. Over time it could modestly support demand for sleep-monitoring devices, blackout and low-blue lighting products, and nonpharmacological sleep-hygiene services in psychiatric care, while posing no material threat to antipsychotic or sedative drugmakers.

healthcare medical research pharmaceuticals

A cross-sectional study from the LENS (Light Exposure and Neurobiology in Schizophrenia) project found that greater nighttime light exposure is associated with objectively measured sleep disruption in adult outpatients with schizophrenia. Researchers from University Health School of Medicine and Okehazama Hospital in Aichi, Japan, analyzed 225 adult outpatients over seven consecutive days using wrist actigraphy, a bedside portable photometer, sleep diaries, and the Pittsburgh Sleep Quality Index. Median nighttime illuminance was 1.4 lux by actigraphy and 4.1 lux by photometer. After adjusting for age, sex, smoking, body mass index, psychiatric symptoms, daytime light, sleep timing, day length, and medications, participants in the highest nighttime-light group had 10% lower sleep efficiency, 55.6 fewer minutes of total sleep, longer sleep onset, and 31 more minutes of wakefulness after sleep onset than the lowest-light group. Higher blue-light exposure showed similar associations. Notably, the association appeared in objective actigraphy measures but not in the subjective Pittsburgh Sleep Quality Index, possibly because the questionnaire covered the previous month while devices measured one week prospectively. The study was led by Yuichi Esaki and student Ryota Miyake, with Nakao Iwata and Tsuyoshi Kitajima of University Health and Kiyoshi Fujita of Okehazama Hospital. It was made available online on June 23, 2026, and scheduled for publication in Psychiatry Research Volume 364 on October 1, 2026. Funding came from JSPS KAKENHI grant 24K10721 and the Autism Science Foundation. The authors stress the findings show association, not causation, and call for longitudinal and intervention trials. Reducing bedroom light is framed as a possible low-cost, nonpharmacological addition to existing care, not a substitute for treatment.

priv
The university led the LENS study through its School of Medicine in Aichi, Japan, and is the primary institutional source of the research. The publication raises its research profile in psychiatric sleep science but has no direct financial effect.
Importance 95.0 Sentiment 5.0
per
Esaki is the lead researcher of the LENS study from University Health. The findings add to his academic standing but have no market effect.
Importance 70.0 Sentiment 3.0
per
Miyake is the student lead author quoted on the study's findings about nighttime light and sleep disruption. His role is academic with no direct market impact.
Importance 65.0 Sentiment 3.0
priv
The Aichi hospital contributed co-author Kiyoshi Fujita and patient-outpatient research capacity to the LENS study. Its role is supportive and carries no direct market consequence.
Importance 55.0 Sentiment 3.0
per
Iwata is a co-author from University Health's Department of Psychiatry. His contribution is academic and financially immaterial.
Importance 45.0 Sentiment 2.0
per
Kitajima is a co-author from University Health's Department of Psychiatry. His contribution is academic and financially immaterial.
Importance 45.0 Sentiment 2.0
per
Kiyoshi Fujita is a co-author from Okehazama Hospital in Aichi. His contribution is academic and financially immaterial.
Importance 45.0 Sentiment 2.0
cnt
Japan is the setting of the study and home to the participating institutions and the 225 outpatients studied. The research has no measurable effect on Japanese markets or sovereign standing.
Importance 30.0 Sentiment 2.0
ngo
The foundation helped fund the LENS study. The grant is a small philanthropic research outlay with no material financial consequence.
Importance 25.0 Sentiment 2.0
ngo
JSPS funded the study through KAKENHI grant 24K10721. The funding is a routine public research grant with no material market effect.
Importance 25.0 Sentiment 2.0
ngo
The WHO is cited for the estimate that schizophrenia affects about 24 million people worldwide, roughly one in 300. It is referenced as a data source only and is not an actor in the event.
Importance 15.0 Sentiment 1.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.